P. Dei Tos

A quality control program for mutation detection in KIT and PDGFRA in gastrointestinal stromal tumours

J. Coindre, M. Debiec‐Rychter, S. Pilotti, 2011, Journal of Gastroenterology.

Genomic index predicts clinical outcome of intermediate-risk gastrointestinal stromal tumours, providing a new inclusion criterion for imatinib adjuvant therapy.

E. Wardelmann, F. Chibon, P. Lagarde, 2015, European journal of cancer.

Genomic index predicts clinical outcome of intermediate-risk gastrointestinal stromal tumours, providing a new inclusion criterion for imatinib adjuvant therapy.

E. Wardelmann, F. Chibon, P. Lagarde, 2015, European journal of cancer.